PATENT CLAIM ANALYSIS

Application Number: 15919394
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["702", "019000"]

Abstract:
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

Claim (Index 5):
A method of treating prostate cancer in a patient comprising: (1) obtaining a sample comprising prostate cancer tumor tissue from said patient; (2) determining by quantitative PCR of cDNA the expression of a panel of genes comprising NUSAP1 and UBE2C in said sample comprising prostate cancer tumor tissue; (3) prognosing said patient as having an increased likelihood of prostate cancer progression when the expression of the genes NUSAP1 and UBE2C in said sample is higher than the expected expression of the genes NUSAP1 and UBE2C in prostate cancer tumor tissue from a reference population; and (4) administering to said patient one or more of chemotherapy, radiation therapy or surgery based on the prognosis.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.16667
- Patent Class: 702.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15588458', '13819963', '13316821', '10342887', '13534529']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.1816653435880625
- 35 USC 102 Novelty (BERT): 0.6313162264406423
- Combined Prediction Score: 0.2266304318733205
- Mean Citation Score: 393.58408
- Max Citation Score: 618.9634
- Similarity Product: 534.4560060457944

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test